Cidara Therapeutics (CDTX) Research & Development: 2017-2025
Historic Research & Development for Cidara Therapeutics (CDTX) over the last 9 years, with Sep 2025 value amounting to $35.5 million.
- Cidara Therapeutics' Research & Development rose 185.86% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.8 million, marking a year-over-year increase of 299.27%. This contributed to the annual value of $71.9 million for FY2024, which is 95.52% up from last year.
- Cidara Therapeutics' Research & Development amounted to $35.5 million in Q3 2025, which was up 43.16% from $24.8 million recorded in Q2 2025.
- In the past 5 years, Cidara Therapeutics' Research & Development registered a high of $46.9 million during Q4 2024, and its lowest value of $5.9 million during Q1 2024.
- Moreover, its 3-year median value for Research & Development was $12.4 million (2024), whereas its average is $18.4 million.
- Examining YoY changes over the last 5 years, Cidara Therapeutics' Research & Development showed a top increase of 485.19% in 2024 and a maximum decrease of 68.63% in 2024.
- Quarterly analysis of 5 years shows Cidara Therapeutics' Research & Development stood at $19.0 million in 2021, then climbed by 5.77% to $20.1 million in 2022, then tumbled by 60.17% to $8.0 million in 2023, then soared by 485.19% to $46.9 million in 2024, then spiked by 185.86% to $35.5 million in 2025.
- Its last three reported values are $35.5 million in Q3 2025, $24.8 million for Q2 2025, and $24.6 million during Q1 2025.